Brokerages Set The Cooper Companies, Inc. (NASDAQ:COO) Target Price at $117.00

The Cooper Companies, Inc. (NASDAQ:COO) has received a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are presently covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $117.00.

COO has been the subject of a number of research reports. Stifel Nicolaus reissued a “buy” rating and issued a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Wells Fargo & Company increased their price objective on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Robert W. Baird boosted their target price on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, November 20th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th.

Insider Activity

In related news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the transaction, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. The trade was a 41.03 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the transaction, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at $520,488.54. This trade represents a 24.94 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cooper Companies

Large investors have recently modified their holdings of the business. Innealta Capital LLC purchased a new stake in Cooper Companies during the 2nd quarter valued at about $25,000. Ashton Thomas Securities LLC acquired a new position in Cooper Companies in the 3rd quarter worth approximately $25,000. Covestor Ltd increased its holdings in Cooper Companies by 305.9% in the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock worth $28,000 after buying an additional 208 shares during the period. Crewe Advisors LLC boosted its holdings in shares of Cooper Companies by 286.4% in the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after acquiring an additional 252 shares during the last quarter. Finally, Tortoise Investment Management LLC increased its stake in shares of Cooper Companies by 75.4% in the second quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock worth $34,000 after acquiring an additional 169 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.9 %

Shares of COO stock opened at $100.80 on Wednesday. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The firm has a market cap of $20.07 billion, a P/E ratio of 56.00, a PEG ratio of 2.15 and a beta of 0.99. The company has a 50 day moving average of $105.91 and a 200-day moving average of $98.34. Cooper Companies has a 12-month low of $82.21 and a 12-month high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. The firm had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.84 EPS. Sell-side analysts anticipate that Cooper Companies will post 3.65 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.